Microviable Therapeutics will be attending LSX Inv€$tival Showcase
Claudio Hidalgo, PhD, cofounder and CEO and Noelia Martínez, PhD, cofounder and R&D Director at Microviable Therapeutics, will be attending LSX Inv€$tival Showcase in London on November 17th. LSX is taking place on the first day of London Life Science Week, bringing together investors, VCs and biotech leaders from around the globe.
Claudio Hidalgo will be presenting our company on Monday 17th, at 13:20 at the Biotech Startup Stage 1.
“I am glad that we were selected among other biotech, medtech and healthtech companies, giving us the opportunity to present to international investors and corporate ventures. We at Microviable Therapeutics SL continue our endeavors of biological medicines development for oncology and infectious diseases, always using naturally existing bacteria from the microbiome as a drug modality“.
Claudio and Noelia will have the opportunity to join other international biotech companies driving innovation at the forefront to improve human health, surrounded by a wide list of investors and the venture arms of the main pharmaceutical companies.
You can reach out to us through the partnering platform of the event to schedule a meeting and the see the full agenda of the event for more details.
Check the information on the event website: https://informaconnect.com/investival-showcase/
